RESUMO
Osteoporosis is a well-established clinical problem in adults. Osteoporosis in pediatrics, on the other hand, is a new and evolving area, with certain unique diagnostic and clinical challenges. Recently, there has been an increased awareness of osteoporosis in children, both as a primary problem due to genetic mutations and enzyme deficiencies, and as secondary to various diseases, medications, and lifestyle issues. In this review we discuss the common forms of osteoporosis, including candidate genes, mutations of which can lead to primary osteoporosis, the mechanisms involved in the pathogenesis of secondary bone loss, and possible ways of diagnosing, preventing, or treating these conditions. The purpose of the article is to provide a summary of our current knowledge of pediatric bone problems and to provide a basis for discussion of the most appropriate ways to detect, treat, or prevent such problems.
Assuntos
Doenças Ósseas/complicações , Doenças Ósseas/genética , Osteoporose/genética , Criança , HumanosRESUMO
We previously reported that bone marrow stromal cells produce insulin-like growth factors (IGF-I and -II), and that medium conditioned by marrow stromal cells stimulates osteoblast proliferation in vitro. The present study employed the rat tail-suspension model to unload the hindlimbs. It was designed to test the hypothesis that the development of osteopenia or osteoporosis could be due to a deficit in the osteogenic function of marrow stromal cells. Although tail suspension suppressed body weight during the first 3 days of an 11-day pair-fed study, the overall weight gain recorded by these animals was normal. Nevertheless, bone growth was inhibited by suspension. Similarly, the total adherent marrow stromal cell population harvested from the femurs and tibias was decreased by tail suspension, and only half the normal number of fibroblastic stromal cell colonies grew when they were cultured. The proliferation of alkaline-phosphatase-positive cells in the stroma was also inhibited. Northern hybridization revealed that the messenger RNA level for transforming growth factor-beta 2 and IGF-II in stromal cell was reduced by tail suspension. The production of IGF-II by marrow stromal cells was also decreased. The steady-state level of five different transcript sizes of IGF-I mRNA was altered differentially by tail suspension. Osteopontin mRNA was also reduced in marrow stromal cells from tail-suspended rats compared with the normal rats. These data suggest that skeletal unloading not only alters the mRNA level for growth factors and peptide production, but also affects the proliferation and osteogenic differentiation of marrow stromal cells. These changes may be responsible for the reduced bone formation in osteopenia and osteoporosis.
Assuntos
Doenças Ósseas Metabólicas/etiologia , Células da Medula Óssea , Regulação da Expressão Gênica no Desenvolvimento/genética , Osteogênese/genética , Osteoporose/etiologia , Animais , Adesão Celular/genética , Diferenciação Celular/genética , Divisão Celular/genética , Células Cultivadas , Colágeno/genética , Fêmur/citologia , Masculino , Osteoblastos/citologia , Osteoblastos/fisiologia , Osteopontina , RNA Mensageiro/genética , Distribuição Aleatória , Ratos , Ratos Wistar , Sialoglicoproteínas/genética , Somatomedinas/genética , Células Estromais/citologia , Células Estromais/fisiologia , Cauda , Tíbia/citologia , Fator de Crescimento Transformador beta/genética , Suporte de CargaRESUMO
Burn patients are at risk for bone disease due to aluminum (Al) exposure from use of antacids and albumin, partial immobilization, and increased production of endogenous glucocorticoids. Moreover, severely burned children are growth impaired up to 3 years after the burn. To determine the extent of bone disease, we studied nine men and three women, ages 18-41 years, with greater than 50% body surface area burn. Seven patients underwent iliac crest bone biopsy following double tetracycline labeling, one additional patient expired after a single label, and three others had postmortem specimens obtained for quantitative Al only. Serial serum and urine samples were obtained weekly until biopsy or death. All biopsied patients had reduced bone formation and osteoid area, surface, and width, with mineral apposition rate, osteoblast surface, and osteoclast number with normal eroded surfaces compared to age- and sex-matched normal ambulatory volunteers. Burn patients also had reduced bone formation, mineral apposition rate, osteoid area, and surface compared to age-matched volunteers at short-term bed rest. Serum levels of osteocalcin were low. Most patients had mild hypercalcemia but only a third had hypercalciuria. All patients had elevated Al in blood or urine; urine Al correlated inversely with serum osteocalcin. In 60% significant bone Al was detectable by stain or quantitation. Our data are compatible with burn patients having markedly reduced bone turnover. Al loading, partial immobilization, endogenous corticosteroids, and cytokine production may be among the etiologic factors.
Assuntos
Alumínio/efeitos adversos , Doenças Ósseas/etiologia , Queimaduras/complicações , Adolescente , Adulto , Alumínio/metabolismo , Doenças Ósseas/induzido quimicamente , Osso e Ossos/metabolismo , Osso e Ossos/patologia , Queimaduras/terapia , Feminino , Glucocorticoides/biossíntese , Humanos , Masculino , Osteocalcina/sangue , Fatores de RiscoRESUMO
Burn injury in children is associated with low bone formation and long-term bone loss. Because recombinant human GH (rHGH) may accelerate burn wound healing, and because rHGH increases bone formation and density in GH-deficient patients, we studied the short-term effects of rHGH on bone fomation, reflected by osteocalcin and type I procollagen propeptide levels in a randomized, double-blind, placebo-controlled study. Nineteen patients were enrolled and received either rHGH (0.2 mg/kg.day) or an equal volume of saline. Mean burn size and age were not different between the groups, and test substances were given from admission to time of wound healing (mean: 43 +/- 22 days). At wound healing, serum levels of insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-3 in the rHGH group rose to mean values of 229% and 187% of the respective means of the placebo group (P < 0.025). Serum osteocalcin concentrations remained below normal in both groups, and type I procollagen propeptide levels achieved a low normal level IGFBR-4 levels were twice that of normal on admission and doubled further at wound healing; IGFBP-5 levels were low on admission but rose to normal at wound healing. We conclude that large doses of rHGH were ineffective in improving disordered bone formation despite increasing serum IGF-1 and IGFBP-3. The rHGH-independent rise in serum levels of the inhibitory binding protein IGFBP-4 suggests a mechanism by which improved bone formation is prevented despite successful elevation of IGF-1 and IGFBP-3 in the burned child.
Assuntos
Desenvolvimento Ósseo/efeitos dos fármacos , Queimaduras/terapia , Hormônio do Crescimento Humano/uso terapêutico , Proteínas de Ligação a Fator de Crescimento Semelhante a Insulina/sangue , Osteocalcina/sangue , Cicatrização , Biomarcadores/sangue , Densidade Óssea/efeitos dos fármacos , Queimaduras/sangue , Queimaduras/fisiopatologia , Criança , Pré-Escolar , Método Duplo-Cego , Feminino , Humanos , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Proteína 4 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Proteína 5 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Fator de Crescimento Insulin-Like I/metabolismo , Masculino , Proteínas Recombinantes/uso terapêutico , Coluna VertebralRESUMO
It has been a dozen years since aluminum was first shown to contaminate parenteral nutrition solutions and to be a contributing factor in the pathogenesis of metabolic bone disease in parenteral nutrition patients as well as in uremic patients. However, there are no regulations in place to effectively reduce aluminum contamination of various parenterally administered nutrients, drugs, and biologic products. The purpose of this review is fourfold: 1) to summarize our knowledge of the adverse effects of aluminum on bone formation and mineralization in parenteral nutrition patients; 2) to discuss the possible role of aluminum in the osteopenic bone disease of preterm infants; 3) to show how lack of regulations covering aluminum content of parenteral solutions can lead to vulnerability of new groups of patients to aluminum toxicity, the example being given here is that of burn patients; and 4) to trace the development of efforts at regulating the aluminum contamination of large- and small-volume parenteral drug products and to point out what still needs to be done in this regard.
Assuntos
Alumínio/efeitos adversos , Nutrição Parenteral Total , Animais , Cálcio/metabolismo , Contaminação de Alimentos , Humanos , Osteomalacia/induzido quimicamenteRESUMO
The characteristics of bone disease associated with parenteral nutrition are controversial. To further elucidate the contribution of aluminum deposition to this syndrome and the spectrum of pathology in patients supported by current regimens utilizing crystalline amino acids, quantitative histomorphometry and staining for Al were performed on iliac crest bone biopsies from 26 long-term parenteral nutrition patients and 16 normal volunteers. Compared with normal subjects, median trabecular bone area (TBA) for a group with positive Al staining (n = 14) who were exposed to casein hydrolysate was significantly less (12.9% vs 20.7, p less than 0.05) as was the median rate of bone formation (RBF) (29 micron2 X mm-2 X d-1 vs 360, p less than 0.05). A variety of abnormal histological findings were present in patients without positive aluminum stains (n = 12) who were supported solely by regimens utilizing crystalline amino acids. However, neither decreased TBA (median TBA = 15.3%) nor decreased RBF (median RBF = 126 micron2 X mm-2 X d-1) was uniformly characteristic of the latter patient group.
Assuntos
Osso e Ossos/patologia , Nutrição Parenteral Total/efeitos adversos , Adulto , Alumínio/metabolismo , Biópsia , Doenças Ósseas/metabolismo , Doenças Ósseas/patologia , Osso e Ossos/metabolismo , Feminino , Humanos , Assistência de Longa Duração , Masculino , Pessoa de Meia-Idade , Coloração e RotulagemRESUMO
Patients on long-term total parenteral nutrition were found to have elevated aluminum (AI) levels in bone, and plasma, with the casein in the total parenteral nutrition solution the source of A1. Substitution of amino acids for casein was followed by a fall in urinary and plasma A1. Thus, parenteral loading with A1 increases tissue A1, particularly in bone. Whether A1 accumulation contributes to bone disease remains unclear, but the prolonged use of casein in total parenteral nutrition solutions may be inadvisable.
Assuntos
Alumínio/metabolismo , Caseínas/administração & dosagem , Nutrição Parenteral Total , Nutrição Parenteral , Adulto , Idoso , Alumínio/análise , Alumínio/sangue , Alumínio/urina , Aminoácidos/administração & dosagem , Doenças Ósseas/etiologia , Osso e Ossos/metabolismo , Caseínas/análise , Feminino , Humanos , Enteropatias/terapia , Masculino , Pessoa de Meia-Idade , Osteomalacia/metabolismo , Nutrição Parenteral/efeitos adversos , Nutrição Parenteral Total/efeitos adversos , Hidrolisados de Proteína/administração & dosagemRESUMO
Bone disease with total parenteral nutrition (TPN) has been attributed to aluminum loading or vitamin D therapy. We studied 17 patients who first received TPN containing casein hydrolysate with high Al and ergocalciferol (25 micrograms/d) for 6-72 mo followed by TPN containing amino acids with reduced Al and ergocalciferol (5 micrograms/d) for 9-58 mo. We also did a cross-sectional study of 22 patients receiving casein and ergocalciferol (25 micrograms/d) compared with 46 patients receiving amino acids and ergocalciferol (5 micrograms/d) for 6-58 mo. Bone formation was higher and osteoid area, bone-surface stainable Al and total bone Al were lower with amino acid TPN than with casein TPN. Bone formation varied inversely with both plasma Al and bone-surface Al, suggesting that plasma or bone-surface Al, acquired during TPN, can reduce bone formation and lead to patchy osteomalacia. Serum levels of iPTH and 1,25-dihydroxyvitamin D were higher with amino acid TPN.
Assuntos
Alumínio/administração & dosagem , Aminoácidos/administração & dosagem , Doenças Ósseas Metabólicas/etiologia , Caseínas/efeitos adversos , Nutrição Parenteral Total/efeitos adversos , Hidrolisados de Proteína/efeitos adversos , Desenvolvimento Ósseo , Doenças Ósseas Metabólicas/metabolismo , Osso e Ossos/análise , Cálcio/análise , Creatinina/análise , Ergocalciferóis/análise , Humanos , Taxa de Depuração Metabólica , Osteomalacia/etiologiaRESUMO
Severe burns in adults is associated with an uncoupling of normal remodeling, low bone formation without reduced resorption. The risk of osteopenia that may occur under such circumstances is heightened by our detection in a cross-sectional study of low bone mass in severely burned children. We report here the acute histomorphometric and biochemical response of bone to severe burn injury, as well as bone mass in severely burned children. We enrolled 24 patients ages 5.8 to 17.5 years following burns of 63 +/- 16% (SD) body surface area. Serum and urine were collected weekly until iliac crest bone biopsy was obtained 26 +/- 10 days postburn. Seventeen of 18 patients, including 5 patients receiving growth hormone treatment to accelerate wound healing, failed to take up doxycycline in trabecular bone, and had no detectable osteoblasts at the osteoid seam, while eroded surface was normal and osteoblasts were documented by staining. Thus, bone formation was virtually absent. There was an eightfold elevation in urinary free cortisol excretion and high serum levels of acute phase reactants and interleukin-1 beta and -6. Biochemical markers of bone formation, osteocalcin, and type I procollagen propeptide were low, as were resorptive markers urinary pyridinoline and deoxypyridinoline. However, there was no correlation with resorptive surface. Mean age-related z-score for bone mass was -1.06 +/- 1.05, 40 days postburn. Immobilization and endogenous corticosteroid production may be the main factors responsible for acutely reduced bone formation while inflammatory cytokines may mediate resorption.
Assuntos
Densidade Óssea/fisiologia , Queimaduras/fisiopatologia , Ílio/patologia , Absorciometria de Fóton , Adolescente , Antibacterianos/administração & dosagem , Antibacterianos/farmacologia , Biomarcadores/sangue , Biomarcadores/urina , Biópsia , Densidade Óssea/efeitos dos fármacos , Desenvolvimento Ósseo/fisiologia , Reabsorção Óssea/fisiopatologia , Queimaduras/sangue , Queimaduras/patologia , Queimaduras/urina , Criança , Doxiciclina/administração & dosagem , Doxiciclina/farmacologia , Feminino , Hormônio do Crescimento/administração & dosagem , Hormônio do Crescimento/farmacologia , Humanos , Ílio/efeitos dos fármacos , Ílio/lesões , Ílio/ultraestrutura , Vértebras Lombares/patologia , Vértebras Lombares/fisiopatologia , Masculino , Osteoblastos/citologia , Osteoblastos/efeitos dos fármacos , Cicatrização/efeitos dos fármacosRESUMO
Aluminum contaminates several chemical compounds that are administered intravenously to patients. The most highly contaminated are calcium and phosphate salts, followed by albumin and heparin. Parenteral administration of aluminum bypasses the gastrointestinal tract, which serves as a protective barrier to aluminum entry into the blood. In the past, parenteral administration of aluminum as a contaminant of water used in hemodialysis and of casein hydrolysate, the former source of protein in parenteral nutrition solutions, was associated with a low-turnover osteomalacic bone disease and, in the case of uremic patients, encephalopathy. Groups currently at risk for aluminum accumulation in tissue resulting from parenteral administration include premature infants receiving long-term parenteral nutrition and patients receiving plasmapheresis therapy with albumin. Both groups may develop metabolic bone disease; the pathogenesis may involve aluminum. The Food and Drug Administration is currently considering regulation of aluminum in fluids used for parenteral nutrition. No changes are presently proposed with regard to albumin.
Assuntos
Alumínio/intoxicação , Contaminação de Medicamentos , Nutrição Parenteral/efeitos adversos , Alumínio/administração & dosagem , Animais , Humanos , Infusões ParenteraisRESUMO
BACKGROUND: The hypermetabolic response to burn increases protein catabolism. Euglycemic hyperinsu-linemia with exogenous insulin maintains muscle protein by continued stimulation of net protein synthesis. Our aim was to determine the effect of euglycemic hyperinsulinemia over the entire hospitalization on muscle anabolism by investigating lean body mass (LBM) as the primary endpoint. METHODS: Eighteen subjects between the ages of 2 and 18 with burns of more than 40% were prospectively randomized into 2 groups, a control (n = 9) and a treatment group (n = 9). The treatment group was given continuous intravenous insulin at a rate of at least 1.5 microU/kg/min to maintain serum glucose levels between 100 to 140 mg/dL. Treatment was instituted 24 to 48 hours after arrival and continued until the patient's injury was 95% healed. All patients received continuous enteral feeding. Patients underwent body composition studies by dual-energy x-ray absorptiometry (DEXA) scan on postoperative day 6 after initial burn excision and when 95% healed. RESULTS: Nutritional intakes were not different between groups. In the control, subjects continued catabolism resulted in peripheral muscle wasting and centripetal obesity with diminished truncal LBM. The treatment group had improvement in lean body mass (P =.004) and bone mass (P =.025). The treatment group also had less peripheral muscle wasting with overall increases in upper/lower extremity LBM (P =.005). Hospital length of stay in days per percent of total body surface area burned was decreased in the insulin group (control = 1.03 +/- 0.1 vs 0.7 +/- 0.9 for insulin patients; P <.05). CONCLUSIONS: Euglycemic hyperinsulinemia throughout the hospital course mitigates muscle catabolism and preserves lean body mass.
Assuntos
Queimaduras/tratamento farmacológico , Queimaduras/metabolismo , Hiperinsulinismo/metabolismo , Hipoglicemiantes/administração & dosagem , Insulina/administração & dosagem , Adulto , Glicemia , Composição Corporal , Peso Corporal , Calorimetria Indireta , Criança , Pré-Escolar , Eletrólitos/sangue , Metabolismo Energético/efeitos dos fármacos , Metabolismo Energético/fisiologia , Feminino , Seguimentos , Técnica Clamp de Glucose , Glicogênio/metabolismo , Humanos , Hiperinsulinismo/induzido quimicamente , Masculino , Músculo Esquelético/metabolismo , Avaliação Nutricional , Estudos ProspectivosRESUMO
BACKGROUND: Food and Drug Administration regulations state that ciprofloxacin hydrochloride may cause arthropathies. For this reason, such therapy is contraindicated in the pediatric population. However, several studies in children with cystic fibrosis have found the drug to be efficacious. Our hypothesis was that ciprofloxacin treatment is justified in the case of multiresistant organisms in burn populations. DESIGN: During a 4-year period (January 1, 1993, to December 31, 1997) we treated 56 of our pediatric burn patients with ciprofloxacin when cultures proved resistant to other antibiotics. The burn area was 65% of the total body surface area. The average patient age was 8.4 years. Of the 56 patients who received ciprofloxacin, 50 received the recommended dose. Biopsy specimens were assessed for quantitative bacteriology and antibiotic sensitivity. Radiologic review was conducted to examine for arthropathy. RESULTS: All patients showed unequivocal reduction in quantitative bacterial counts, and susceptibility to ciprofloxacin remained stable without the development of resistance. Of the 56 patients treated, 42 had a major reduction in their quantitative wound biopsies from 10(6) to less than 100 colonies per gram of tissue, while the remaining 14 were observed to have a 2- to 3-log decrease. No arthropathy was detected in any of the 56 patients receiving ciprofloxacin. Review of the patients' charts showed no documented adverse events associated with the use of ciprofloxacin. All patients survived their thermal injury and the complications associated with it without any untoward problems or complications of arthropathy. CONCLUSION: On the basis of these data, ciprofloxacin therapy in the treatment of immunosuppressed pediatric burn patients is efficacious and does not cause arthropathy.
Assuntos
Anti-Infecciosos/uso terapêutico , Queimaduras/complicações , Ciprofloxacina/uso terapêutico , Infecção Hospitalar/tratamento farmacológico , Infecção Hospitalar/etiologia , Resistência a Múltiplos Medicamentos , Infecção dos Ferimentos/tratamento farmacológico , Infecção dos Ferimentos/etiologia , Adolescente , Fatores Etários , Biópsia , Criança , Pré-Escolar , Monitoramento de Medicamentos , Feminino , Humanos , Lactente , Artropatias/induzido quimicamente , Artropatias/diagnóstico por imagem , Masculino , Radiografia , Estudos RetrospectivosRESUMO
Health care services and resources for older persons living in rural areas may be highly variable, and integrated service-delivery models are often lacking. This article presents a managed-care model of nutrition risk screening and intervention for older persons in rural areas. Nutrition risk screening was implemented by the Geisinger Health Care System, Danville, Pa, to target all eligible enrollees in a regional Medicare risk program. A single remote clinic site participating in the managed health care system was chosen for further study of a linked screening and case-management effort for undernourished persons. Screening and intervention at the clinic site selected for this study were guided by centralized expertise and resources. Individualized evaluation and intervention plans were developed with the aid of a dietitian and implemented by the clinic case manager. Of the 417 subjects who completed screening at the remote site, 68 met the risk criteria for undernutrition and were selected for case management. Many of the targeted persons received interventions that included evaluations by a physician or physician extender (eg, physician assistant, nurse practitioner) at the clinic and consultations with nutrition, mental health, or social services professionals. Twenty-six of the subjects who took part in the intervention completed a follow-up screening 6 months later. Ten of those persons no longer exhibited risk criteria. This demonstrates the feasibility of a linked screening and case management program for nutrition risk in the managed-care setting.
Assuntos
Nível de Saúde , Programas de Assistência Gerenciada/organização & administração , Estado Nutricional , Serviços de Saúde Rural/organização & administração , Idoso , Administração de Caso/organização & administração , Humanos , Modelos Organizacionais , PennsylvaniaRESUMO
Parenteral nutrition-associated metabolic bone disease in children is manifested primarily as osteopenia and, on occasion, fractures. The etiology is likely multifactorial, with calcium and phosphate deficiency playing a major role in the preterm infant and with the role of aluminum toxicity yet to be clearly defined in this population. Lack of normal values of bone histomorphometry in the premature infant as well as lack of normal data for biochemical markers of bone turnover in these patients contribute to the uncertainty. Other factors that may play a role in the pathogenesis include lack of periodic enteral feeding; underlying intestinal disease, including malabsorption and inflammation; the presence of neoplasms; and drug-induced alterations in calcium and bone metabolism. The true incidence and prevalence of parenteral nutrition-associated bone abnormalities in pediatric patients remain unknown.
Assuntos
Doenças Ósseas/etiologia , Nutrição Parenteral Total/efeitos adversos , Alumínio/administração & dosagem , Alumínio/efeitos adversos , Doenças Ósseas Metabólicas/etiologia , Osso e Ossos/lesões , Fraturas Ósseas/etiologia , Humanos , Lactente , Recém-Nascido , Vitamina D/fisiologiaRESUMO
Prolonged total parenteral nutrition (TPN) with solutions containing hydrolyzed casein has been associated with aluminum accumulation in patients with bone disease. We investigated the effects of free amino acids in TPN solution on plasma, urine, and bone aluminum in six patients, five of whom had symptoms of bone disease or documented demineralization. No evidence of aluminum accumulation was found. TPN with free amino acids, containing 42 micrograms aluminum per liter or less, does not lead to aluminum loading in adolescents or adults.
Assuntos
Alumínio/metabolismo , Aminoácidos/uso terapêutico , Alimentos Formulados , Nutrição Parenteral Total , Adolescente , Adulto , Idoso , Alumínio/toxicidade , Doenças Ósseas/induzido quimicamente , Osso e Ossos/análise , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nutrição Parenteral Total/efeitos adversos , Fatores de TempoRESUMO
Cholestasis is a common complication of total parenteral nutrition (TPN) in infants. A contributing factor to the hepatic dysfunction may be a contaminant of the TPN solution, such as aluminum, that accumulates in liver and may act as a hepatotoxin. To study the hepatic effects of aluminum, growing piglets were given daily intravenous injections of aluminum, 1.5 mg/kg, for 50 days; pair-fed controls were given heparinized saline. At sacrifice, liver and serum were obtained. Liver was analyzed for histopathology and for aluminum content and localization. The hepatocyte lysosomes of the experimental group showed aluminum peaks by x-ray microanalysis, whereas the control group did not. No differences in ultrastructure were noted between the two groups when examined by electron microscopy. Mean serum total bile acid levels (27.8 +/- 15.9 SD vs 6.3 +/- 1.5 mumol/liter, p less than 0.05), mean alkaline phosphatase (309 +/- 108 vs 180 +/- 27 IU/liter, p = NS), and mean hepatic copper content (24.8 +/- 4.5 vs 14.4 +/- micrograms/g dry weight, p less than 0.01), were elevated in the aluminum-loaded piglets, indicating that cholestasis may have been produced. Also, a small but significant reduction in serum levels of 25 hydroxy-vitamin D was found in the aluminum-loaded piglets, suggesting that vitamin D hydroxylation may be impaired. Inasmuch as lysosomal contents are excreted into the bile, aluminum accumulation in lysosomes may alter lysosomal function and possibly affect bile flow or content.
Assuntos
Alumínio/toxicidade , Animais Recém-Nascidos/metabolismo , Fígado/efeitos dos fármacos , Animais , Ácidos e Sais Biliares/sangue , Colestase/induzido quimicamente , Cobre/análise , Microscopia Eletrônica , Nutrição Parenteral Total/efeitos adversos , Suínos , Vitamina D/metabolismoRESUMO
Children and adults who suffer severe burn injuries develop abnormalities in bone and mineral metabolism. The most prominent of these is a reduction in bone formation. Events occurring immediately following burn injury that are likely contributors to the reduced bone formation include an increase in endogenous glucocorticoid production, functional growth hormone deficiency, hypoparathyroidism, and interoperative immobilization. The proinflammatory cytokines interleukin-1 beta and interleukin-6 may also contribute. To date, the effects of burn injury on bone formation have been equivocal. However, the major reduction in bone formation without any consistent change in resorption suggests an uncoupling of formation and resorption. A consequence of this is lumbar spine bone loss as detected by dual-energy X-ray absorptiometry by 6 wk postburn. In both cross-sectional and longitudinal studies, the initial low bone density remains decreased in relation to unburned age-matched peers. The reduced bone density increases the risk for postburn fractures and for reduced peak bone mass, increasing the risk of these patients for adult-onset osteoporosis.
Assuntos
Absorciometria de Fóton , Queimaduras/complicações , Queimaduras/fisiopatologia , Densidade Óssea , Queimaduras/metabolismo , HumanosRESUMO
Allergic rhinitis (hayfever) is a common problem found in the geriatric population. This problem should be aggressively treated with environmental control, prescription nasal sprays and/or antihistamines (if tolerated). Allergy immunotherapy can be a very effective treatment for the elderly, without the side effects commonly found when hayfever medication is used.
Assuntos
Rinite Alérgica Perene/terapia , Corticosteroides/uso terapêutico , Idoso , Poluição do Ar/prevenção & controle , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Humanos , Imunoterapia , Descongestionantes Nasais/uso terapêutico , Rinite Alérgica Perene/tratamento farmacológicoRESUMO
Decreased muscular activity results in weakness and muscular atrophy. Coincident with this protein catabolic state is glucose intolerance and hyperinsulinemia. Rats were tail suspended for 7 to 14 days to accomplish unloading of the hindlimbs. Insulin resistance was documented in these animals by a 14 day tail suspension-related 26% increase in serum glucose in spite of a 253% increase in serum insulin concentration. Microsomal membranes were prepared from hindlimb muscles and specific binding of insulin and insulin-like growth factor I (IGF-I) were determined in these membranes. Insulin binding was decreased by 27% at 7 days and by 21% at 14 days. In contrast, IGF-I binding was unchanged at 7 days and was increased by 24% at 14 days. Liver membrane insulin receptors also had declined by 14 days of suspension, suggesting that the change in insulin receptors was a generalized, humorally-mediated phenomenon. These data suggest that tail suspension in rats results in insulin resistance, hyperinsulinemia, a decline in insulin receptors in liver and muscle, and a relative increase in muscle membrane IGF-I receptors. These data are consistent with the hypothesis that resistance to insulin's effects on protein metabolism in skeletal muscle may contribute to the protein catabolism associated with decreased muscular activity.
Assuntos
Atrofia Muscular/metabolismo , Receptor de Insulina/metabolismo , Animais , Glicemia/metabolismo , Insulina/sangue , Insulina/metabolismo , Fator de Crescimento Insulin-Like I/metabolismo , Membranas Intracelulares/metabolismo , Masculino , Membranas/metabolismo , Microssomos Hepáticos/metabolismo , Ratos , Ratos Sprague-Dawley , Restrição Física , CaudaRESUMO
Aluminum contaminates various fluids that are used in intravenous therapy, and it is associated with bone disease and encephalopathy. Albumin is highly contaminated with aluminum, which is eliminated primarily by renal excretion. Patients with burns receive large quantities of albumin and have impaired renal function, which puts them at hypothetical risk for aluminum loading. To assess the risk of aluminum loading we analyzed sera from 12 patients with burns for aluminum concentrations. Serum aluminum concentration was elevated in 8 of the 12 patients, and levels were at or near toxicity in 3 of the 8. Serum aluminum and serum creatinine levels directly correlated, r = 0.71 and p less than 0.005. No relation was found between serum aluminum and amount of albumin received. However, patients with the highest serum aluminum levels were the most severely burned and none survived. Thus patients with burns who are receiving albumin are at risk for aluminum loading. Impaired renal function contributes to aluminum retention.